Imax (IMAX) Cash & Equivalents (2010 - 2026)

Imax (IMAX) has reported Cash & Equivalents for 17 consecutive years, with $159.9 million the latest figure, recorded in Q2 2026.

• Quarterly Cash & Equivalents rose 46.31% year-over-year to $159.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $159.9 million (up 46.31% YoY) and the FY2025 annual result came in at $151.2 million, up 50.28% from the prior year.
• Cash & Equivalents rose to $159.9 million in Q2 2026 per IMAX's latest filing, from $146.0 million in the prior quarter.
• Over the last five years, Cash & Equivalents for IMAX reached as high as $162.3 million in Q1 2022 and fell as low as $76.2 million in Q4 2023.
• A 5-year average of $112.3 million and a median of $102.5 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 54.82% — and 2026, when it surged 50.4%.
• Year by year, Cash & Equivalents stood at $97.4 million in 2022, then fell by 21.77% to $76.2 million in 2023, then jumped by 32.01% to $100.6 million in 2024, then surged by 50.28% to $151.2 million in 2025, then rose by 5.79% to $159.9 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $159.9 million, $146.0 million, and $151.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.